The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial

Van Keer, Jan; Derthoo, David; Van Caenegem, Olivier; De Pauw, Michel; Nellessen, Eric; Duerinckx, Nathalie; Droogne, Walter; Vörös, Gábor; Meyns, Bart; Belmans, Ann; Janssens, Stefan; Van Cleemput, Johan; Vanhaecke, Johan

doi:10.1155/2017/6347138

The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial

Van Keer, Jan

;

Derthoo, David

;

Van Caenegem, Olivier

;

De Pauw, Michel

;

Vanhaecke, Johan

;et.al.

(2017) Journal of Transplantation — Vol. 2017, n° 2017, p. 1-8 (2017)

Files

JTRANS2017-6347138.pdf

Open Access
Adobe PDF
642.52 KB

Download

Details

Authors

Van Keer, Jan
Author
Derthoo, David
Author
Van Caenegem, OlivierUCLouvain
Author
De Pauw, Michel
Author
Vanhaecke, Johan
Author

Affiliations

Citations

APA
Chicago
FWB

Van Keer, J., Derthoo, D., Van Caenegem, O., De Pauw, M., Nellessen, E., Duerinckx, N., Droogne, W., Vörös, G., Meyns, B., Belmans, A., Janssens, S., Van Cleemput, J., & Vanhaecke, J. (2017). The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial. Journal of Transplantation, 2017(2017), 1-8. https://doi.org/10.1155/2017/6347138 (Original work published 2017)